These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26107799)

  • 1. New medications for treatment of chronic hepatitis C.
    Murfin M
    JAAPA; 2015 Jul; 28(7):57-9. PubMed ID: 26107799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.
    Childs-Kean LM; Hand EO
    Clin Ther; 2015 Feb; 37(2):243-67. PubMed ID: 25601269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis.
    Soriano V; Barreiro P; de Mendoza C; Peña JM
    Antivir Ther; 2016; 21(1):91-2. PubMed ID: 26042495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.
    Collins JM; Raphael KL; Terry C; Cartwright EJ; Pillai A; Anania FA; Farley MM
    Clin Infect Dis; 2015 Oct; 61(8):1304-6. PubMed ID: 26082511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.
    Ende AR; Kim NH; Yeh MM; Harper J; Landis CS
    J Med Case Rep; 2015 Jul; 9():164. PubMed ID: 26215390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis.
    Perumpail RB; Wong RJ; Ha LD; Pham EA; Wang U; Luong H; Kumari R; Daugherty TJ; Higgins JP; Younossi ZM; Kim WR; Glenn JS; Ahmed A
    Transpl Infect Dis; 2015 Apr; 17(2):275-8. PubMed ID: 25641426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis].
    Mar J; Mar-Barrutia L; Gimeno-Ballester V; San Miguel R
    Med Clin (Barc); 2016 Jan; 146(2):61-4. PubMed ID: 26654558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis.
    Modi AA; Nazario H; Trotter JF; Gautam M; Weinstein J; Mantry P; Barnes M; Habib A; McAfee J; Teachenor O; Tujague L; Gonzalez S
    Liver Transpl; 2016 Mar; 22(3):281-6. PubMed ID: 26335142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.
    Saab S; Greenberg A; Li E; Bau SN; Durazo F; El-Kabany M; Han S; Busuttil RW
    Liver Int; 2015 Nov; 35(11):2442-7. PubMed ID: 25913321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the achievement of sustained virological response after liver transplantation.
    Lens S; Mariño Z; Forns X
    Liver Int; 2015 Nov; 35(11):2354-7. PubMed ID: 26189705
    [No Abstract]   [Full Text] [Related]  

  • 11. Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant.
    Punzalan CS; Barry C; Zacharias I; Rodrigues J; Mehta S; Bozorgzadeh A; Barnard GF
    Clin Transplant; 2015 Dec; 29(12):1105-11. PubMed ID: 26358816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients.
    Pérez-Pitarch A; Guglieri-López B; Ferriols-Lisart R; Merino-Sanjuán M
    Int J Antimicrob Agents; 2016 Mar; 47(3):184-94. PubMed ID: 26915476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
    Stern R; Hametner S; Ramona AZ; Moser S; Karpi A; Laferl H; Stauber RE; Zoller HM; Maieron A; Vogel W; Graziadei I; Gschwantler M; Kozbial K; Freissmuth C; Hofer H; Ferenci P
    Am J Gastroenterol; 2016 May; 111(5):744-5. PubMed ID: 27151123
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial Commentary: Another Call to Cure Hepatitis B.
    Balagopal A; Thio CL
    Clin Infect Dis; 2015 Oct; 61(8):1307-9. PubMed ID: 26082512
    [No Abstract]   [Full Text] [Related]  

  • 15. Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
    Pillai AA; Anania FA; Pearlman BL
    Am J Gastroenterol; 2016 Dec; 111(12):1854-1856. PubMed ID: 27924099
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation.
    Thomas P; Santiago T; Dallas MH
    Bone Marrow Transplant; 2016 May; 51(5):735-7. PubMed ID: 26752145
    [No Abstract]   [Full Text] [Related]  

  • 17. The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis.
    Pearlman BL; Ehleben C; Perrys M
    Gastroenterology; 2015 Apr; 148(4):762-70.e2; quiz e11-2. PubMed ID: 25557952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing the face of hepatitis C management - the design and development of sofosbuvir.
    Noell BC; Besur SV; deLemos AS
    Drug Des Devel Ther; 2015; 9():2367-74. PubMed ID: 25987834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation.
    Tavio M; Vivarelli M; Menzo S; Gori A; Grossi PA; Marigliano A
    Liver Transpl; 2015 Oct; 21(10):1327-9. PubMed ID: 26123079
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in hepatitis C therapies.
    Mariño Z; Lens S; Gambato M; Forns X
    Expert Opin Pharmacother; 2015; 16(13):1929-43. PubMed ID: 26219918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.